TGViewer
BioAI BioAI @bioai_desci · 617 subscribers
Post #20 24.4K
Tumor-infiltrating lymphocytes (TILs) have emerged as a promising immunotherapy strategy in recent years, showing significant potential in cancer treatment and becoming a key tool in cancer immunotherapy.

https://www.linkedin.com/pulse/case-studies-tumor-infiltrating-lymphocytes-zn86e
Linkedin Case Studies of Tumor-Infiltrating Lymphocytes (TILs) in Cancer Immunotherapy Tumor-infiltrating lymphocytes (TILs) have emerged as a promising immunotherapy strategy in recent years, showing significant potential in cancer treatment and becoming a key tool in cancer immunotherapy. TILs are immune cells, particularly T cells, found…
  • 🥰 984
  • 🤩 777
  • 👍 541
  • ❤ 473
  • 🔥 365
  • 👏 361
Open in Telegram All posts from @bioai_desci
More from @bioai_desci
  1. May 14, 2025Immune cell therapy is redefining cancer treatment—personalized, targeted, and rooted in t…
  2. May 7, 2025Truly impressive work. An interpretable AI model that deciphers the “language” of protein…
  3. May 5, 2025BioAI: Recharge Your Cells with Oxygen Power 🌬 Cellular energy begins with oxygen. It’s t…
  4. Apr 30, 2025Cancer doesn’t stand a chance when the cure comes from within. Immune cell therapy is chan…
  5. Apr 28, 2025🔬 Advanced assays like residual HEK293 qPCR and AAV genomic titer dPCR are transforming g…
  6. Apr 26, 2025🚀 BioAI: Turn Cells into Cancer Killers Harness the power of CAR-T therapy to reprogram y…
Threads Profile ViewerView any public Threads profile without an account.Open ThreadLook →Writing with AI? Make it sound human.Metric37 rewrites AI drafts so they read naturally. Free AI detector, 1,500 words free.Try Metric37 →